Please see below for an upcoming webinar from NCI's Childhood Cancer Data Initiative.
From: Chung, Sisley (NIH/NCI) [C] <sisley.chung@nih.gov>
Sent: Wednesday, March 18, 2026 9:57 AM
To: Karen Knight <kknight@naaccr.org>
Subject: CCDI Webinar: Molecular Targeted Therapies Reveal Glioma Cell Plasticity Linked to Immune Evasion in BRAF-Mutant Brain Tumors
Join the National Cancer Institute for our next Childhood Cancer Data Initiative (CCDI) webinar:
Molecular Targeted Therapies Reveal Glioma Cell Plasticity Linked to Immune Evasion in BRAF-Mutant Brain Tumors
Tuesday, April 14, 2026, from 1:00–2:00 p.m. ET
Dr. Claudia Petritsch from Stanford University School of Medicine will lead a discussion on cancer models in oncology: why we need new models, what can be achieved with these models, and how National Institutes of Health initiatives are helping address critical gaps in cancer model development.
She will also present her recent study on therapy resistance in BRAF-mutant brain tumors. Oncogenic BRAF alterations activate MAP-kinase signaling across many different neoplasias, including primary brain tumors, resulting in cellular proliferation and survival. Despite the success of molecular therapies-in particular BRAF and MEK inhibition as frontline care for selected brain tumor patients-therapy resistance is common, with underlying mechanisms still needing investigation.
Join us to learn more about her findings!
If you are an individual with a disability who needs reasonable accommodations to participate in this event, please email CCDIevents@mail.nih.gov by April 7.
Speaker:
Claudia Petritsch, Ph.D.
Associate Professor in Research
Department of Neurosurgery
Stanford University School of Medicine
For more information about CCDI events, visit our Events & Webinars page.
Sisley Chung
Manager, Marketing Strategy & Analysis
Contractor: Publicis Sapient
National Cancer Institute
National Institutes of Health
Shady Grove/2E320
sisley.chung@nih.gov